Delivery Order SPE2DB24D2100-SPE2DB25FBFKC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,365.73 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) on July 22, 2025, with completion scheduled for July 23, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical supply transaction executed under the company's existing contract vehicle with DLA. The award was placed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.16 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray in 16GM units. This firm fixed-price, competitively awarded delivery order was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the company's Conshohocken, Pennsylvania location. The award carries no set-aside designation, reflecting AmerisourceBergen's ability to compete successfully in open...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,073.79 for Fluticasone Propionate 50 MCG Spray in 16GM units, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract employs firm fixed price pricing and represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,442.40 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 microgram nasal spray in 16-gram units. This firm fixed-price delivery order, issued on July 24, 2025, represents a competitive award with no set-aside designation and is scheduled for ultimate completion by July 25, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,214.68 to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray in 16-gram units. This non-competitive, firm fixed-price delivery order was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,694.16 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Fluticasone Propionate 50 micrograms nasal spray (16 grams). The contract employs firm fixed price terms with an ultimate completion date of July 28, 2025, and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its Corporate Office location. This delivery order represents a competitive award...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,788.39 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563589134 - FLUTICASONE PROP 50 MCG SPRAY 16GM. This contract has a completion date of February 8, 2024 and was awarded on February 7, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone Prop 50 MCG Spray 16GM. The contract has a ceiling value of $2,903.99 and a performance period ending on May 1, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,841.46 to AmerisourceBergen Drug Corp for the supply of Fluticasone Propionate 50 MCG Spray (16GM), a corticosteroid nasal spray medication used for allergy and inflammatory conditions. This competitively awarded, firm fixed-price contract with no set-aside designation was executed on July 18, 2025, with an ultimate completion date of July 21, 2025. The point of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $1,232.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 micrograms nasal spray (16 grams) on July 18, 2025, with an ultimate completion date of July 21, 2025. This contract was not designated under any set-aside program and represents a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFKCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Fluticasone Propionate 50 MCG Spray (16GM) with a ceiling value of $1,756.80 under firm fixed price terms. This delivery order, issued on July 22, 2025, represents a non-set-aside competitive award with an ultimate completion date of July 23, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical federal medical procurement vendor for military and veteran healthcare systems, supplying an extensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The company's competitive awards across DLA's Medical Supply Chain demonstrate its capability to meet federal procurement requirements and support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/22/25 |